Moderna Says Its COVID-19 Vaccine Is Safe and Effective in 12- to 17-Year-Olds

On Tuesday, Moderna announced the results of their Phase 2 trial of the administration of their COVID-19 vaccine to children ages 12 to 17

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting